Sponsored Sessions


Saturday, June 24, 2017 Supported by

11:15-11:45

Satellite Lecture 1
Chairperson: Dimitrios Ioannides (Greece)

Management of nails psoriasis in the era of biologic agents
  • Burden of disease
  • Nails disease as a predictor of psoriatic arthritis
  • Treatment options and recommendations
Stamatios Gregoriou (Greece)

Saturday, June 24, 2017 Supported by

12:15-13:15

Satellite Symposium: THE IMPACT OF IL-17A INHIBITION IN PSORIASIS, PSORIATIC ARTHRITIS AND DIFFICULT-TO-TREAT PSORIASIS
Chairpersons: Dimitrios Rigopoulos (Greece) – Dimitrios Ioannidis (Greece)
12:15-12:45 A new target for the long-term management of psoriasis
Elisavet Lazaridou (Greece)
12:45-13:15 A new approach for the management of psoriatic arthritis and difficult-to-treat psoriasis
Marina Papoutsaki (Greece)

Saturday, June 24, 2017 Supported by


14:45-15:15

Satellite Lecture 2: IL12/23 INHIBITION IN PLAQUE PSORIASIS WITH SPECIAL INTEREST IN THE EFFECTIVENESS ON NAIL DISEASE
 14:55 – 15:15 The contribution of IL12/23 inhibition in the treatment of nail psoriasis
Natalia Rompoti (Greece)
 14:45 – 14:55 Improving quality of life in patients with nail psoriasis
Dimitrios Rigopoulos (Greece)

Saturday, June 24, 2017 Supported by


17:30-18:00

Satellite Lecture 3: INHIBITION OF PHOSPHODIESTERASE-4 AS A DIFFERENT THERAPEUTIC APPROACH OF NAIL PSORIASIS
Chairperson: Dimitrios Ioannides (Greece)

Focusing on nail psoriasis
Dimitrios Ioannides (Greece)

Clinical data of apremilast in patients with nail psoriasis
Dimitrios Rigopoulos (Greece)